Sticky honey helps icky acne
1 September 2015 | By Charlotte Batchelor
Large clinical trial shows that a New Zealand kanuka honey formulation helps acne...
List view / Grid view
News
European marketing authorisation granted for Alexion’s Kanuma™ (sebelipase alfa)
1 September 2015 | By Nick Jackson
Alexion Pharmaceuticals, Inc. has announced that the European Commission has approved Kanuma™ (sebelipase alfa) for long-term enzyme replacement therapy in patients of all ages with lysosomal acid lipase deficiency...
Abbott announces positive results of its naturally dissolving stent from ABSORB Japan study
1 September 2015 | By Nick Jackson
Abbott has announced positive one-year clinical results from ABSORB Japan, a multi-center, randomised trial comparing the safety and effectiveness of Abbott's fully dissolving AbsorbTM heart stent to XIENCE®...
First patient recruited in Pollinex Quattro Birch dose ranging study in Germany and Austria
1 September 2015 | By Nick Jackson
As a precursor to the Phase III trial, this Phase IIb study will select the optimum dose, and is being conducted in Germany under the Therapy Allergens Ordinance (Therapieallergene-Verordnung)...
Mylan shareholders approve proposed acquisition of Perrigo
28 August 2015 | By Victoria White
Mylan's proposed acquisition of Perrigo received the approval of two-thirds of the votes cast by Mylan shareholders at an extraordinary general meeting...
FDA approves LDL cholesterol drug Repatha
28 August 2015 | By Victoria White
Repatha, the second drug approved in a new class of drugs known as PCSK9 inhibitors, has been approved by the FDA for some patients who are unable to get their LDL cholesterol under control with current treatment options...
Novartis donates $40 million of treatments to treat leprosy
28 August 2015 | By Victoria White
Novartis has renewed its pledge with the World Health Organisation (WHO) to work to end leprosy by extending its donation of multidrug therapy medicines...
Celgene completes acquisition of Receptos for $7.2 billion
28 August 2015 | By Victoria White
Celgene has completed its acquisition of Receptos, significantly enhancing Celgene’s Inflammation & Immunology pipeline with the addition of Ozanimod...
Pharma leaders gather in Madrid at the CPhI Pre-Connect Congress
28 August 2015 | By Victoria White
CPhI Worldwide will once again be preceded by the Pre-Connect Congress when the global pharma community returns to Madrid October 13-15th...
Synjardy tablets receive FDA approval for adults with type 2 diabetes
27 August 2015 | By Nick Jackson
Synjardy approval was based on multiple clinical trials showing reductions in blood glucose versus placebo...
HRA Pharma launches ellaOne® website for pharmacists
27 August 2015 | By Nick Jackson
HRA Pharma UK and Ireland has announced the launch of ellaonepharmacist.co.uk, a brand new website designed specifically for healthcare professionals which provides an educational resource for ellaOne® (30mg ulipristal acetate) accessible anytime.
Ablynx announces half-year results for 2015
27 August 2015 | By Nick Jackson
Ablynx has announced its business update and results for the six-month period ending 30 June 2015...
Combination of Roche medicines Cotellic and Zelboraf approved in Switzerland for the treatment of patients with advanced melanoma
27 August 2015 | By Nick Jackson
New treatment option for patients with difficult-to-treat form of skin cancer has shown improved treatment outcomes...
FDA approves Praluent for the treatment of high LDL cholesterol
26 August 2015 | By Victoria White
The US Food and Drug Administration (FDA) has approved Praluent (alirocumab) Injection - the first and only PCSK9 inhibitor approved in the US...
Alvogen to acquire four Pfizer products for the US market
26 August 2015 | By Victoria White
Alvogen is to acquire four pharmaceutical products from Pfizer, strengthening Alvogen’s commercial platform in the US market...
